The Role of Orbital Radiotherapy in the Management of Thyroid Related Orbitopathy

作者: Michael Kazim

DOI: 10.1007/3-540-29969-6_8

关键词:

摘要: The treatment protocol for orbital radiotherapy published in 1973 by Donaldson et al. has been adopted all radation oncology centers worldwide Patients are presently exposed to a total of 20 Gy delivered ten fractional sessions with the beam directed at retro-ocular tissues,posteriorly 5°, avoid excessive exposure retina and lens While there is no clear understanding mechanism which low-dose radiation modulates local inflammatory response orbit, number vitro studies provide evidence suggest multiple mechanisms currently held model thyroid associated orbitopathy may be modified blunt downstream consequences fibroblast activation The majority patients suffering Graves’ not candidates radiotherapy Patients mild disease or stable phase will benefit from when compared natural history disease In more severely affected patients, reversal optic neuropathy, improvement extraocular motility decrease congestive signs symptoms can anticipated after

参考文章(35)
Ulrich Schaefer, Stefan Hesselmann, Oliver Micke, Patrick Schueller, Frank Bruns, Curro Palma, Normann Willich, A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy International Journal of Radiation Oncology Biology Physics. ,vol. 52, pp. 192- 197 ,(2000) , 10.1016/S0360-3016(01)01754-0
Colum A Gorman, James A Garrity, Vahab Fatourechi, Rebecca S Bahn, Ivy A Petersen, Scott L Stafford, John D Earle, Glenn S Forbes, Robert W Kline, Erik J Bergstralh, Kenneth P Offord, Diana M Rademacher, Nancy M Stanley, George B Bartley, A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves’ ophthalmopathy Ophthalmology. ,vol. 108, pp. 1523- 1534 ,(2001) , 10.1016/S0161-6420(01)00632-7
Iris M.M.J Wakelkamp, Hendra Tan, Peerooz Saeed, Reinier O Schlingemann, Frank D Verbraak, Leo E.C.M Blank, Mark F Prummel, Wilmar M Wiersinga, Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study Ophthalmology. ,vol. 111, pp. 1557- 1562 ,(2004) , 10.1016/J.OPHTHA.2003.12.054
C. Marcocci, L. Bartalena, F. Bogazzi, G. Bruno-Bossio, A. Pinchera, Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy. Experimental and Clinical Endocrinology & Diabetes. ,vol. 97, pp. 332- 337 ,(2009) , 10.1055/S-0029-1211088
Ivy A Petersen, Joseph P Kriss, I.Ross McDougall, Sarah S Donaldson, Prognostic factors in the radiotherapy of graves' ophthalmopathy International Journal of Radiation Oncology Biology Physics. ,vol. 19, pp. 259- 264 ,(1990) , 10.1016/0360-3016(90)90532-O
Colum A Gorman, James A Garrity, Vahab Fatourechi, Rebecca S Bahn, Ivy A Petersen, Scott L Stafford, John D Earle, Glenn S Forbes, Robert W Kline, Helmut Buettner, Dennis M Robertson, Erik J Bergstralh, Kenneth P Offord, Diana M Rademacher, Nancy M Stanley, George B Bartley, The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology. ,vol. 109, pp. 2100- 2107 ,(2002) , 10.1016/S0161-6420(02)01293-9
M Just, G Kahaly, H P Higer, H P Rösler, J Kutzner, J Beyer, M Thelen, Graves ophthalmopathy: role of MR imaging in radiation therapy. Radiology. ,vol. 179, pp. 187- 190 ,(1991) , 10.1148/RADIOLOGY.179.1.2006276
Per Olof Gedda, Martin Lindgren, Pituitary and Orbital Roentgen Therapy in the Hyperophthalmopathic Type of Graves' Disease Acta Radiologica. ,vol. 42, pp. 211- 220 ,(1954) , 10.3109/00016925409174479
Claudio Marcocci, L. Bartalena, F. Bogazzi, G. Bruno-Bossio, A. Lepri, A. Pinchera, Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study Journal of Endocrinological Investigation. ,vol. 14, pp. 853- 860 ,(1991) , 10.1007/BF03347943
K. Hermann, Pituitary Exophthalmos An Assessment of Methods of Treatment British Journal of Ophthalmology. ,vol. 36, pp. 1- 19 ,(1952) , 10.1136/BJO.36.1.1